Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation

International Immunopharmacology

Volumn 17, Issue 1, 2013, Pages 116-122

  Zhao, Jijun ^a   Zhang, Hui ^a   Huang, Yuefang ^a   Wang, Hongyue ^a   Wang, Shuang ^a   Zhao, Chunmei ^a   Liang, Yingjie ^a   Yang, Niansheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bay11 7082; Lupus nephritis; NF B; NLRP3 inflammasome

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CRYOPYRIN; DIMETHYL SULFOXIDE; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL;

EID: 84879486085     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.05.027     Document Type: Article

References (33)

1. Faurschou M, Dreyer L, Kamper AL, Starklint H, Jacobsen S. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken) 2010;62:873-80.
2. Grande JP. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring. Lupus 1998;7:604-10. (Pubitemid 29008226)
3. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11. (Pubitemid 32047405)
4. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004;18:2195-224.
5. Enzler T, Bonizzi G, Silverman GJ, Otero DC, Widhopf GF, Anzelon-Mills A, et al. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 2006;25: 403-15. (Pubitemid 44354213)
6. Zheng L, Sinniah R, Hsu SI. Pathogenic role of NF-kappaB activation in tubuleinterstitial inflammatory lesions in human lupus nephritis. J Histochem Cytochem 2008;56:517-29. (Pubitemid 351556494)
7. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011;117:3720-32.
8. IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988;141:3050-4.
9. Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821-32.
10. Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011;29:707-35.
11. Shin MS, Kang Y, Lee N, Kim SH, Kang KS, Lazova R, et al. U1-small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes. J Immunol 2012;188:4769-75.
12. Kahlenberg JM, Carmona-Rivera C, Smith CK, Kaplan MJ. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol 2013;190:1217-26.
13. Shin MS, Kang Y, Lee N, Wahl ER, Kim SH, Kang KS, et al. Self double-stranded (ds) DNA induces IL-1β production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies. J Immunol 2013;190: 1407-15.
14. Strickson S, Campbell DG, Emmerich CH, Knebel A, Plater L, Ritorto MS, et al. The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signaling network by targeting the ubiquitin system. Biochem J 2013;451: 427-37.
15. Juliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, Yu JW, et al. Antiinflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J Biol Chem 2010;285:9792-802.
16. Kar S, Ukil A, Das PK. Cystatin cures visceral leishmaniasis by NF-κB-mediated proinflammatory response through co-ordination of TLR/MyD88 signaling with p105-Tpl2-ERK pathway. Eur J Immunol 2011;41:116-27.
17. Deng GM, Tsokos GC. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. J Immunol 2008;181: 4019-26.
18. Zhang L, Yang N, Wang S, Huang B, Li F, Tan H, et al. Adenosine 2A receptor is protective against renal injury in MRL/lpr mice. Lupus 2011;20:667-77.
19. Michaelson JS, Wisniacki N, Burkly LC, Putterman C. Role of TWEAK in lupus nephritis: a bench-to-bedside review. J Autoimmun 2012;39:130-42.
20. Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 2011;13:250.
21. Rangan GK, Wang Y, Tay YC, Harris DC. Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int 1999;56:118-34. (Pubitemid 29300527)
22. Takase O, Hirahashi J, Takayanagi A, Chikaraishi A, Marumo T, Ozawa Y, et al. Gene transfer of truncated IkappaBalpha prevents tubulointerstitial injury. Kidney Int 2003;63:501-13. (Pubitemid 36126796)
23. Tsai PY, Ka SM, Chang JM, Chen HC, Shui HA, Li CY, et al. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic Biol Med 2011;51:744-54.
24. Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 2010;21:1732-44.
25. Kulkarni O, Pawar RD, Purschke W, Eulberg D, Selve N, Buchner K, et al. Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas) lpr mice. J Am Soc Nephrol 2007;18:2350-8. (Pubitemid 47203851)
26. Singh RG, Usha, Rathore SS, Behura SK, Singh NK. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Lupus 2012;21:1214-8.
27. Rosa RF, Takei K, Araújo NC, Loduca SM, Szajubok JC, Chahade WH. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. J Rheumatol 2012;39:1948-54.
28. Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010;411:1570-9.
29. Wang Y, Rangan GK, Goodwin B, Tay YC, Harris DC. Lipopolysaccharide- induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int 2000;57:2011-22. (Pubitemid 30252293)
30. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 1997;272:31092-9. (Pubitemid 27527558)
31. Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, Atkins RC, et al. Local macrophage proliferation in human glomerulonephritis. Kidney Int 1998;54:143-51. (Pubitemid 28288028)
32. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-808. (Pubitemid 38063703)
33. V, Liu Q, Shu X, Sun A, Sun Q, Zhang C, et al. Plant-derived small molecule albaconol suppresses LPS-triggered proinflammatory cytokine production and antigen presentation of dendritic cells by impairing NF-kappaB activation. Int Immunopharmacol 2008;8:1103-11.